Safranal Induces Vasorelaxation by Inhibiting Ca<sup>2+</sup> Influx and Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Isolated Rat Aortic Rings

<b>Introduction:</b> Safranal, which endows saffron its unique aroma, causes vasodilatation and has a hypotensive effect in animal studies, but the mechanisms of these effects are unknown. In this study, we investigated the mechanisms of safranal vasodilation. <b>Methods:</b>...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Noor Nadhim Al-Saigh, Shtaywy Abdalla
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/13/4228
Description
Summary:<b>Introduction:</b> Safranal, which endows saffron its unique aroma, causes vasodilatation and has a hypotensive effect in animal studies, but the mechanisms of these effects are unknown. In this study, we investigated the mechanisms of safranal vasodilation. <b>Methods:</b> Isolated rat endothelium-intact or -denuded aortic rings were precontracted with phenylephrine and then relaxed with safranal. To further assess the involvement of nitric oxide, prostaglandins, guanylate cyclase, and phospholipase A<sub>2</sub> in safranal-induced vasodilation, aortic rings were preincubated with L-NAME, indomethacin, methylene blue, or quinacrine, respectively, then precontracted with phenylephrine, and safranal concentration–response curves were established. To explore the effects of safranal on Ca<sup>2+</sup> influx, phenylephrine and CaCl<sub>2</sub> concentration–response curves were established in the presence of safranal. Furthermore, the effect of safranal on aortic rings in the presence of ouabain, a Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor, was studied to explore the contribution of Na<sup>+</sup>/Ca<sup>2+</sup> exchanger to this vasodilation. <b>Results:</b> Safranal caused vasodilation in endothelium-intact and endothelium-denuded aortic rings. The vasodilation was not eliminated by pretreatment with L-NAME, indomethacin, methylene blue, or quinacrine, indicating the lack of a role for NO/cGMP. Safranal significantly inhibited the maximum contractions induced by phenylephrine, or by CaCl<sub>2</sub> in Ca<sup>2+</sup>-free depolarizing buffer. Safranal also relaxed contractions induced by ouabain, but pretreatment with safranal totally abolished the development of ouabain contractions. <b>Discussion/Conclusion:</b> Inhibition of Na<sup>+</sup>-K<sup>+</sup> ATPase by ouabain leads to the accumulation of Na<sup>+</sup> intracellularly, forcing the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger to work in reverse mode, thus causing a contraction. Inhibition of the development of this contraction by preincubation with safranal indicates that safranal inhibited the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger. We conclude that safranal vasodilation is mediated by the inhibition of calcium influx from extracellular space through L-type Ca<sup>2+</sup> channels and by the inhibition of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger.
ISSN:1420-3049